Physician

Robert C. Hood, M.D.,F.R.C.P.C.

According to 2025 Medicare claims, Robert Hood, M.D., F.R.C.P.C. (NPI: 1053321539) practices endocrinology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is ENDOCRINE CLINIC OF SOUTHEAST TEXAS (NPI: 1336159847; TIN: 760509654) and primary practice location at 77702-1424.

Hood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 767 traditional Medicare patients, billed 95,580 HCPCS/CPT codes, and received $1,294,399 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 3,576 prescription claims across 587 beneficiaries totaling $1,411,316 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,009 claims. Open Payments data shows 312 records totaling $132,069. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $547,513 to $1,294,399. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $35,441 to $311,001.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	859	33,954	$547,513
2016	819	36,428	$574,670
2017	808	44,123	$688,974
2018	793	43,860	$726,970
2019	801	48,078	$788,973
2020	792	47,717	$772,019
2021	719	63,669	$990,589
2022	738	67,024	$1,005,398
2023	784	87,368	$1,205,892
2024	767	95,580	$1,294,399

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	647	6,650	$1,580,658
2016	616	6,460	$1,624,778
2017	635	6,184	$1,810,828
2018	610	5,641	$1,654,399
2019	580	4,856	$1,569,089
2020	559	4,479	$1,453,673
2021	543	4,000	$1,305,010
2022	558	4,021	$1,502,639
2023	578	4,175	$1,802,094
2024	587	3,576	$1,411,316

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	510	1,245	$67,719
2016	575	1,242	$82,600
2017	406	836	$98,607
2018	337	891	$131,135
2019	281	875	$141,503
2020	268	938	$148,355
2021	178	855	$142,975
2022	244	1,029	$163,434
2023	271	1,193	$221,807
2024	289	1,009	$315,516

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	641	1,788	$9
82310	Calcium level, total	523	1,139	$5
82565	Blood creatinine level	543	1,118	$5
84132	Blood potassium level	546	1,143	$5
84520	Urea nitrogen level to assess kidney function, quantitative	558	1,264	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	215	9,986	$320,072
Mounjaro	Tirzepatide	150	7,052	$247,745
Jardiance	Empagliflozin	140	7,396	$139,056
Tresiba Flextouch U-200	Insulin Degludec	72	4,652	$93,747
Trulicity	Dulaglutide	46	2,606	$85,905

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	111	509	$200,730
E0784	External ambulatory infusion pump, insulin	Y	17	138	$46,447
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	16	63	$27,226
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	32	93	$22,893
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	32	91	$7,785

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	312	$132,069	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert C. Hood, M.D., F.R.C.P.C.?

Tedicare shows public-source Medicare data for Robert C. Hood, M.D., F.R.C.P.C. (NPI 1053321539), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert C. Hood, M.D., F.R.C.P.C. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert C. Hood, M.D., F.R.C.P.C.?

Robert C. Hood, M.D., F.R.C.P.C. is linked to ENDOCRINE CLINIC OF SOUTHEAST TEXAS (billing NPI 1336159847) in the available physician profile data.

Does Robert C. Hood, M.D., F.R.C.P.C. have Open Payments data?

Robert C. Hood, M.D., F.R.C.P.C. has 312 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.